Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endodrill vs. Conventional Biopsy. Diagnostics and Genetic Analysis in Tumors of the Distal Esophagus and Cardia

NCT02601079 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT02601079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02601079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endodrill vs. Conventional Biopsy. Diagnostics and Genetic Analysis in Tumors of the Distal Esophagus and Cardia
Lead sponsor
Region Skane
Phase
Not applicable
Overall status
Terminated
Start date
September 30, 2016
Completion date
June 30, 2019
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal neoplasm